» Authors » John H Joseph

John H Joseph

Explore the profile of John H Joseph including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 168
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Biesman B, Green J, George R, Jacob C, Palm M, Jones D, et al.
Aesthet Surg J . 2024 Apr; 44(9):1001-1013. PMID: 38573527
Background: Hyaluronic acid injections are increasingly administered for correction of infraorbital hollows (IOHs). Objectives: The objective of this study was to examine the effectiveness (IOH correction) and safety of Restylane...
2.
Fagien S, Avelar R, Cox S, Joseph J, Kaufman-Janette J, Marcus K
Aesthet Surg J . 2024 Mar; 44(9):987-1000. PMID: 38506148
Background: Extending the duration of effect of botulinum toxins-by administering doses beyond those of the approved labels-has been an area of increasing interest in the field of aesthetics. Objectives: The...
3.
Joseph J, Foulad A, Hsue V, Romero T, Davis P
J Drugs Dermatol . 2024 Jan; 23(1):1311-1318. PMID: 38206150
Background: AbobotulinumtoxinA (aboBoNT-A) is useful for the treatment of platysmal banding. This study evaluated the efficacy and safety of a standardized 2-staged injection technique using high doses of AboBoNT-A for...
4.
Joseph J, Dayan S, Bhatia A, Fabi S, Shridharani S, Donofrio L, et al.
J Cosmet Dermatol . 2022 Oct; 22(1):177-185. PMID: 36208285
Background: Collagenase clostridium histolyticum-aaes (CCH-aaes) is approved in the United States for moderate-to-severe cellulite in the buttocks of adult women. Aim: Interim analysis to evaluate efficacy/safety of CCH-aaes in the...
5.
Kaufman-Janette J, Joseph J, Dayan S, Smith S, Eaton L, Maffert P
Dermatol Surg . 2022 Sep; 48(10):1065-1070. PMID: 36129233
Background: Maximizing patient comfort during hyaluronic acid gel injection is a common concern that is usually addressed by selecting fillers with lidocaine. Objective: Two randomized, double-blinded, split-face trials aimed to...
6.
Joseph J, Maas C, Palm M, Lain E, Glaser D, Bruce S, et al.
Aesthet Surg J . 2022 Jun; 42(11):1318-1327. PMID: 35704394
Background: OnabotulinumtoxinA 20 U reduces glabellar line (GL) severity at maximum frown for approximately 3 to 4 months. Small studies have suggested that >20-U doses may increase the efficacy and...
7.
Bass L, Kaufman-Janette J, Joseph J, Kaminer M, Clark J, Fabi S, et al.
Plast Reconstr Surg Glob Open . 2022 Jun; 10(5):e4306. PMID: 35646496
Background: Collagen-rich fibrous septae and subcutaneous adipose protrusions play a role in cellulite pathophysiology. Collagenase clostridium histolyticum-aaes (CCH-aaes) injection causes enzymatic release of septae to resolve cellulite depressions and create...
8.
Joseph J, Foulad A, Hakimi A, Azizzadeh B, Biesman B, Wachs F, et al.
J Cosmet Dermatol . 2022 May; 21(7):3163-3165. PMID: 35538667
No abstract available.
9.
Trevidic P, Carey W, Benedetto A, Joseph J, Eaton L, Antunes S, et al.
J Cosmet Dermatol . 2022 Jan; 21(3):949-955. PMID: 35049135
Background: Validated, objective clinical scales are needed to assess aesthetic improvement of the lips after augmentation with dermal fillers. Objective: To develop a lip fullness rating scale and establish its...
10.
Sundaram H, Shamban A, Schlessinger J, Kaufman-Janette J, Joseph J, Lupin M, et al.
Dermatol Surg . 2021 Oct; 48(1):87-93. PMID: 34608092
Background: The perioral region is highly mobile and subject to multifactorial changes during aging. Resilient Hyaluronic Acid Redensity (RHAR), an RHA filler, was developed with the aim of optimizing outcomes...